12:00 AM
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Remune: Phase III testing update

Remune is in Phase III testing with partner Pfizer Inc. (PFE, New York, N.Y.).

The Immune Response Corp. (IMNR), Carlsbad, Calif.
Product: Remune
Business: Infectious diseases
Therapeutic category: Immune...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >